Macrolides as first line therapy in adult lower respiratory tract infections: Pros and cons

Ethan Rubinstein*, Itzhak Levy

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

1 Scopus citations

Abstract

Certain guidelines exist to facilitate the decision as to which patients with lower respiratory tract infections require antibiotics. The decision as to which antibiotic to use must depend on a detailed knowledge of the disease and the patient's condition. Recent recommendations recognize four categories of patients with community-acquired pneumonia and adopt somewhat different treatment strategies for each. In industrialized countries, macrolides are regarded as either first- or second-choice therapy for community-acquired pneumonias of all grades of severity.

Original languageEnglish
Pages (from-to)2S23-2S26
JournalClinical Microbiology and Infection
Volume1
Issue numberSUPPL. 2
DOIs
StatePublished - Jun 1996

Keywords

  • Chlamydia pneumoniae
  • Community-acquired pneumonia
  • Drug treatment
  • Haemophilus influenzae
  • Macrolides

Fingerprint

Dive into the research topics of 'Macrolides as first line therapy in adult lower respiratory tract infections: Pros and cons'. Together they form a unique fingerprint.

Cite this